Cargando…
Enzyme replacement therapy for Fabry disease: some answers but more questions
Fabry disease (FD) is a multisystem, X-linked disorder of glycosphingolipid metabolism caused by enzyme deficiency of α-galactosidase A. Affected patients have symptoms including acroparesthesias, angiokeratomas, and hypohidrosis. More serious manifestations include debilitating pain and gastrointes...
Autores principales: | Alfadhel, Majid, Sirrs, Sandra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061846/ https://www.ncbi.nlm.nih.gov/pubmed/21445281 http://dx.doi.org/10.2147/TCRM.S11987 |
Ejemplares similares
-
Advances in gout: some answers, more questions
por: Singh, Jasvinder A
Publicado: (2010) -
The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process
por: Khan, Aneal, et al.
Publicado: (2021) -
Randomness Through Computation: Some Answers, More Questions
por: Zenil, Hector
Publicado: (2011) -
Bullying victimization and perpetration: some answers and more questions()
por: Voisin, Dexter R., et al.
Publicado: (2023) -
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
por: Golde, Todd E.
Publicado: (2022)